Atlas Trials

Xenon Inhalation for Treatment of Panic Disorder

Clinical trial NCT04432155 · UNKNOWN

Trial details

NCT number
NCT04432155
Sponsor
Nobilis Therapeutics Inc.
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Panic Disorder
Start date
2021-06-01
Primary completion
2021-11-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.